Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion: a possible compensatory mechanism in Parkinson's disease

被引:51
|
作者
Blesa, Javier [1 ,2 ]
Juri, Carlos [1 ,3 ]
Garcia-Cabezas, Miguel A. [4 ,5 ]
Adanez, Rebeca [1 ,2 ]
Sanchez-Gonzalez, Miguel A. [4 ,5 ]
Cavada, Carmen [4 ,5 ]
Obeso, Jose A. [1 ,2 ]
机构
[1] Clin Univ Navarra, Ctr Invest Med Aplicada, Dept Neurol & Neurociugia, Lab Trastornos Movimiento,Neurociencias, Pamplona, Spain
[2] Inst Carlos III, Minist Ciencia & Innovat, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain
[3] Pontificia Univ Catolica Chile, Dept Neurol, Santiago, Chile
[4] Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain
[5] Inst Invest Sanitaria IdiPAZ, Madrid, Spain
来源
FRONTIERS IN SYSTEMS NEUROSCIENCE | 2011年 / 5卷
关键词
MPTP; Parkinson's disease; PET; dopaminergic; F-18-DOPA; compensatory mechanisms;
D O I
10.3389/fnsys.2011.00092
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The onset of Parkinson's disease (PD) is characterized by focal motor features in one body part, which are usually correlated with greater dopaminergic depletion in the contralateral posterior putamen. The role of dopamine (DA) hemispheric differences in the onset and progression of motor symptoms of PD, however, remains undefined. Previous studies have demonstrated that unilateral manipulations of one nigrostriatal system affect contralateral DA turnover, indicating a functional and compensatory inter-dependence of the two nigrostriatal systems. In preliminary data obtained by our group from asymmetric PD patients, a higher asymmetry index as measured by 6-[F-18]fluoro-L-dopa (F-18-DOPA) positron emission tomography (PET) was associated with a higher threshold (i.e., greater dopaminergic loss) for the onset of motor symptoms in the less-affected side. To further elucidate the underlying basis for this, we carried out a complementary study in monkeys using PET to assess and correlate the degree of dopaminergic striatal depletion with motor activity. Control and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated monkeys with symmetrical lesions were characterized behaviorally and with F-18-DOPA PET. In parallel, an acute lesion was inflicted in the nigrostriatal projection unilaterally in one monkey, generating a 30% dopaminergic depletion in the ipsilateral striatum, which was not associated with any noticeable parkinsonian feature or deficit. The monkey remained asymptomatic for several months. Subsequently, this monkey received systemic MPTP, following which motor behavior and PET were repeatedly evaluated during progression of parkinsonian signs. The brains of all monkeys were processed using immunohistochemical methods. Our results suggest that the onset of motor signs is related to and influenced by the dopaminergic status of the less-affected, contralateral striatum. Although this work is still preliminary, the study agrees with our general hypothesis of hemispheric inter-dependence in the compensation of striatal DA deficit in PD
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's disease
    Svenja Happe
    Paul Christian Baier
    Kathrin Helmschmied
    Johannes Meller
    Klaus Tatsch
    Walter Paulus
    Journal of Neurology, 2007, 254 : 1037 - 1043
  • [22] CGP 3466 protects dopaminergic neurons in lesion models of Parkinson's disease
    Waldmeier, PC
    Spooren, WPJM
    Hengerer, B
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2000, 362 (06) : 526 - 537
  • [23] Lesion of the subthalamic nucleus reverses motor deficits but not death of nigrostriatal dopaminergic neurons in a rat 6-hydroxydopamine-lesion model of Parkinson's disease
    Rizelio, V.
    Szawka, R. E.
    Xavier, L. L.
    Achaval, M.
    Rigon, P.
    Saur, L.
    Matheussi, F.
    Delattre, A. M.
    Anselmo-Franci, J. A.
    Meneses, M.
    Ferraz, A. C.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2010, 43 (01) : 85 - 95
  • [24] Dopamine Synthesis in the Nigrostriatal Dopaminergic System in Patients at Risk of Developing Parkinson's Disease at the Prodromal Stage
    Blokhin, Victor
    Pavlova, Ekaterina N.
    Katunina, Elena A.
    Nodel, Marina R.
    Kataeva, Galina V.
    Moskalets, Elina R.
    Pronina, Tatiana S.
    Ugrumov, Michael V.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (03)
  • [25] Oestrogen and nigrostriatal dopaminergic neurodegeneration: Animal models and clinical reports of Parkinson's disease
    Liu, Bin
    Dluzen, Dean E.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2007, 34 (07) : 555 - 565
  • [26] Perspective: Identification of genetic variants associated with dopaminergic compensatory mechanisms in early Parkinson's disease
    Greenbaum, Lior
    Lorberboym, Mordechai
    Melamed, Eldad
    Rigbi, Amihai
    Barhum, Yael
    Kohn, Yoav
    Khlebtovsky, Alexander
    Lerer, Bernard
    Djaldetti, Ruth
    FRONTIERS IN NEUROSCIENCE, 2013, 7
  • [27] Effect of Different Doses of Estrogen on the Nigrostriatal Dopaminergic System in Two 6-Hydroxydopamine-Induced Lesion Models of Parkinson's Disease
    Cordellini, Marcela Ferreira
    Piazzetta, Giovana
    Pinto, Karin Cristine
    Delattre, Ana Marcia
    Matheussi, Francesca
    Carolino, Ruither O. G.
    Szawka, Raphael Escorsim
    Anselmo-Franci, Janete A.
    Ferraz, Anete Curte
    NEUROCHEMICAL RESEARCH, 2011, 36 (06) : 955 - 961
  • [28] Effect of Different Doses of Estrogen on the Nigrostriatal Dopaminergic System in Two 6-Hydroxydopamine-Induced Lesion Models of Parkinson’s Disease
    Marcela Ferreira Cordellini
    Giovana Piazzetta
    Karin Cristine Pinto
    Ana Márcia Delattre
    Francesca Matheussi
    Ruither O. G. Carolino
    Raphael Escorsim Szawka
    Janete A. Anselmo-Franci
    Anete Curte Ferraz
    Neurochemical Research, 2011, 36 : 955 - 961
  • [29] Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease
    Drui, G.
    Carnicella, S.
    Carcenac, C.
    Favier, M.
    Bertrand, A.
    Boulet, S.
    Savasta, M.
    MOLECULAR PSYCHIATRY, 2014, 19 (03) : 358 - 367
  • [30] Nigrosome 1 visibility and its association with nigrostriatal dopaminergic loss in Parkinson's disease
    Kim, Han-Kyeol
    Kim, Tae Won
    Baek, Min Seok
    Kim, Eung Yeop
    Sung, Young Hee
    Lee, Jae Hoon
    Ryu, Young Hoon
    Ahn, Sung Jun
    Yoo, Han Soo
    Lyoo, Chul Hyoung
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (06) : 1639 - 1647